Topics

Navidea Biopharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update

16:05 EDT 1 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Conference Call to be held Wednesday, May 8, 2019 at 5:00 p.m. (EDT) Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagno...

Other Sources for this Article

Navidea Biopharmaceuticals, Inc.
Jed Latkin, CEO, 614-973-7490
jlatkin@navidea.com

NEXT ARTICLE

More From BioPortfolio on "Navidea Biopharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update"

Quick Search

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...